Stay updated with breaking news from Pierre Bizzari. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Ameet Mallik, Chief Executive Officer of ADC Therapeutics, also joins the Board ADC Therapeutics SA (NYSE: ADCT) today announced the appointment of veteran oncology drug developer Jean-Pierre Bizzari
Dr Jacques Medioni and Dr Jean-Pierre Bizzari join company’s scientific board – bringing their extensive oncology expertise to help Seekyo enter clinic with SKY01 drug candidate targeting solid tumorsPoitiers, France, January 17, 2022 – Seekyo, a startup company specializing in developing smart chemotherapy drugs, t...